Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs United States Oil ETF — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while United States Oil ETF trades at $153.52 (market cap $1.86B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 2.7× United States Oil ETF's market cap, and United States Oil ETF is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and United States Oil ETF for 21 Days on average.
| ORKA | USO | |
|---|---|---|
Market Cap | $5.08B | $1.86B |
Volume | 685,276 | 2,900,350 |
Sector | Health | — |
52-Week High | $113.08 | $161.86 |
52-Week Low | $26.19 | $66.17 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $4.21B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USO is trading at $153.09, up 1.36% with a bullish technical outlook supported by strong moving average signals. Recent news highlights ongoing Middle East tensions affecting oil supply chains, with OPEC+ maintaining steady output targets while G-7 nations plan strategic fuel releases to curb prices. The stock shows positive momentum despite mixed oscillators and geopolitical uncertainties.
The outlook remains cautiously optimistic with technical strength offset by fundamental data gaps and geopolitical risks. Investment opportunity exists if supply disruptions persist, but volatility from political events and coordinated government interventions pose significant near-term risks for energy sector investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
